ClinVar Genomic variation as it relates to human health
NM_004928.3(CFAP410):c.218G>C (p.Arg73Pro)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_004928.3(CFAP410):c.218G>C (p.Arg73Pro)
Variation ID: 428573 Accession: VCV000428573.41
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 21q22.3 21: 44333188 (GRCh38) [ NCBI UCSC ] 21: 45753071 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Sep 9, 2017 Nov 24, 2024 Oct 9, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_004928.3:c.218G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_004919.1:p.Arg73Pro missense NM_001271440.2:c.218G>C NP_001258369.1:p.Arg73Pro missense NM_001271441.2:c.218G>C NP_001258370.1:p.Arg73Pro missense NM_001271442.1:c.95G>C NP_001258371.1:p.Arg32Pro missense NC_000021.9:g.44333188C>G NC_000021.8:g.45753071C>G NG_032952.1:g.11215G>C - Protein change
- R73P, R32P
- Other names
-
CFAP410, ARG73PRO (rs140451304)
- Canonical SPDI
- NC_000021.9:44333187:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00015
Trans-Omics for Precision Medicine (TOPMed) 0.00026
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CFAP410 | - | - |
GRCh38 GRCh37 |
360 | 515 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
no assertion criteria provided
|
Aug 1, 2015 | RCV000492059.4 | |
Likely pathogenic (2) |
criteria provided, single submitter
|
Apr 1, 2021 | RCV000504803.5 | |
Likely pathogenic (1) |
no assertion criteria provided
|
Jan 1, 2015 | RCV000504995.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jun 26, 2019 | RCV001075775.3 | |
Pathogenic/Likely pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Apr 1, 2024 | RCV001091473.32 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Oct 9, 2024 | RCV001376208.3 | |
CFAP410-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Sep 10, 2024 | RCV003409679.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 26, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal dystrophy
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV001241408.1
First in ClinVar: Apr 18, 2020 Last updated: Apr 18, 2020
Comment:
My Retina Tracker patient
|
|
|
Likely pathogenic
(Apr 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001369095.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PP5.
|
|
Likely pathogenic
(Apr 08, 2021)
|
criteria provided, single submitter
Method: research
|
Retinal dystrophy with or without macular staphyloma
Affected status: yes
Allele origin:
germline
|
Ocular Genomics Institute, Massachusetts Eye and Ear
Accession: SCV001573267.1
First in ClinVar: May 10, 2021 Last updated: May 10, 2021 |
Comment:
The C21orf2 c.218G>C variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we … (more)
The C21orf2 c.218G>C variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PS3, PP1. Based on this evidence we have classified this variant as Likely Pathogenic. (less)
|
|
Likely pathogenic
(Apr 01, 2021)
|
criteria provided, single submitter
Method: curation
|
Retinitis pigmentosa
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Accession: SCV001950220.1
First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
Comment:
The p.Arg73Pro variant in C21orf2 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics … (more)
The p.Arg73Pro variant in C21orf2 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PM2, PS3, PP1. Based on this evidence we have classified this variant as Likely pathogenic. If you have any questions about the classification please reach out to the Pierce Lab. (less)
|
|
Pathogenic
(Jan 17, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002064174.2
First in ClinVar: Jan 29, 2022 Last updated: Mar 04, 2023 |
Comment:
Published functional studies demonstrate a damaging effect with loss of C21orf2 protein function (Wheway et al., 2015); In silico analysis supports that this missense variant … (more)
Published functional studies demonstrate a damaging effect with loss of C21orf2 protein function (Wheway et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27596865, 26974433, 26167768, 28422394, 28041643, 29343210, 31980526, 28771251, 32036094, 32581362, 31431468) (less)
|
|
Pathogenic
(Jan 22, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001411421.5
First in ClinVar: Jul 16, 2020 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 73 of the CFAP410 protein (p.Arg73Pro). … (more)
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 73 of the CFAP410 protein (p.Arg73Pro). This variant is present in population databases (rs140451304, gnomAD 0.07%). This missense change has been observed in individuals with Jeune asphyxiating thoracic dystrophy, cone-rod dystrophy or retinitis pigmentosa (PMID: 26167768, 27596865). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 428573). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CFAP410 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects CFAP410 function (PMID: 26167768). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Apr 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001247540.26
First in ClinVar: May 12, 2020 Last updated: Oct 20, 2024 |
Comment:
CFAP410: PM3:Very Strong, PP1:Strong, PM2, PS3:Supporting, BP4
Number of individuals with the variant: 6
|
|
Pathogenic
(Oct 09, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal dystrophy with or without macular staphyloma
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV005398911.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism … (more)
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with retinal dystrophy with macular staphyloma (MIM#617547) and axial spondylometaphyseal dysplasia (MIM#602271). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to proline. (I) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 90 heterozygotes, 0 homozygotes). (SP) 0309 - Multiple alternative amino acid changes at the same position has been observed in gnomAD (v2) (highest allele count: 5 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and low conservation. (I) 0600 - Variant is located in the annotated leucine-rich repeat domain (PMID: 26974433). (I) 0710 - Other missense variants comparable to the one identified in this case have inconclusive previous evidence for pathogenicity. The variants p.(Arg73Gly), p.(Arg73Cys), and p.(Arg73His) have each been reported as variants of uncertain significance by a clinical laboratory (ClinVar). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple individuals with axial spondylometaphyseal dysplaisa (PMID: 26974433) and Jeune asphyxiating thoracic dystrophy (PMIDs: 26167768, 28422394). In addition, it has been reported as pathogenic/likely pathogenic by multiple clinical laboratories (ClinVar). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
|
Likely pathogenic
(Jan 01, 2015)
|
no assertion criteria provided
Method: research
|
Retinitis pigmentosa
Affected status: yes
Allele origin:
unknown
|
NIHR Bioresource Rare Diseases, University of Cambridge
Accession: SCV000599093.1
First in ClinVar: Sep 09, 2017 Last updated: Sep 09, 2017 |
Number of individuals with the variant: 1
Sex: female
Ethnicity/Population group: European
|
|
Likely pathogenic
(Jan 01, 2015)
|
no assertion criteria provided
Method: research
|
Cone-rod dystrophy
Affected status: yes
Allele origin:
unknown
|
NIHR Bioresource Rare Diseases, University of Cambridge
Accession: SCV000599094.1
First in ClinVar: Sep 09, 2017 Last updated: Sep 09, 2017 |
Number of individuals with the variant: 1
Sex: female
Ethnicity/Population group: European
|
|
Pathogenic
(Aug 01, 2015)
|
no assertion criteria provided
Method: literature only
|
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000580653.3
First in ClinVar: Jun 26, 2017 Last updated: Sep 03, 2018 |
Comment on evidence:
In 5 sibs (family GC4693) with retinal dystrophy, severe scoliosis, and hip dysplasia (SMDAX; 602271), Wheway et al. (2015) identified homozygosity for a c.218G-C transversion … (more)
In 5 sibs (family GC4693) with retinal dystrophy, severe scoliosis, and hip dysplasia (SMDAX; 602271), Wheway et al. (2015) identified homozygosity for a c.218G-C transversion (c.218G-C, NM_004928.2) in the C21ORF2 gene, resulting in an arg73-to-pro (R73P) substitution at a highly conserved residue within a leucine-rich repeat (LRR) domain. Their unaffected mother was heterozygous for the mutation, which was present in the Exome Variant Server database at a minor allele frequency of 0 to 0.01% and in the ExAC database at 0.03304% (37/111,976 alleles). DNA was unavailable from their unaffected father. In 2 of the male sibs, splenomegaly and reduced sperm motility were also observed. In a brother and sister from an unrelated family from Northern Ireland (UCL-111) who exhibited narrow thorax and pelvic bone malformations on skeletal surveys and developed retinal degeneration in childhood, Wheway et al. (2015) identified compound heterozygosity for the R73P mutation and a c.671T-C transition in C21ORF2, resulting in a leu224-to-pro (L224P; 603191.0002) substitution. A third sib from family UCL-111 who also carried both mutations had only cone-rod dystrophy and did not show any skeletal anomalies. Exogenous expression of the R73P or L224P variant in mIMCD3 cells partially rescued ciliogenesis after siRNA knockdown of endogenous C21orf2, suggesting that they represent hypomorphic mutations. In addition, R73P mutant RNA rescued the nek1 (604588)-null zebrafish phenotype less effectively than wildtype C21ORF2, and the L224P mutant had little effect, confirming the hypomorphic effect of both variants. In a Turkish mother and son with SMDAX, and the mother's affected sister, as well as a 28-year-old Swedish woman, Wang et al. (2016) identified homozygosity for the R73P mutation in the C21ORF2 gene, located in the second LLR domain in the N-terminal conserved region. The mutation was absent in 100 Turkish controls, but was present in the ESP6500 and ExAC databases at very low allele frequencies (0.0154% and 0.0334%, respectively). Wang et al. (2016) stated that the skeletal phenotypes of the patients reported by Wheway et al. (2015) with the R73P mutation, who were studied as part of a Jeune syndrome (see 208500) cohort, were similar to their own axial SMD patients. In a 30-year-old woman with short stature, extremely narrow thorax, severe scoliosis, and retinal dystrophy, McInerney-Leo et al. (2017) identified homozygosity for the recurrent R73P mutation in the C21ORF2 gene. The authors stated that this patient exhibited features of both Jeune syndrome and axial SMD, and noted that the extent of her thoracic involvement appeared to be more severe than in other C21ORF2-associated cases. (less)
|
|
Pathogenic
(Sep 10, 2024)
|
no assertion criteria provided
Method: clinical testing
|
CFAP410-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004109827.3
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The CFAP410 c.218G>C variant is predicted to result in the amino acid substitution p.Arg73Pro. This variant has been reported as segregating with disease in both … (more)
The CFAP410 c.218G>C variant is predicted to result in the amino acid substitution p.Arg73Pro. This variant has been reported as segregating with disease in both the homozygous and compound heterozygous states in kindreds with Jeune syndrome or cone-rod dystrophy (Table S8, Wheway et al. 2015. PubMed ID: 26167768). This variant has also been reported along with a second CFAP410 variant in large cohort studies of retinal disease (Table S2, Carss et al. 2017. PubMed ID: 28041643; Zhang et al. 2016. PubMed ID: 27596865; Table S1, Lin. 2024. PubMed ID: 38219857). Additionally, this variant has been reported in the homozygous state in two families with axial spondylometaphyseal dysplasia (Wang et al. 2016. PubMed ID: 26974433). Functional studies suggested that p.Arg73Pro is a hypomorphic variant (Wheway et al. 2015. PubMed ID: 26167768). This variant is reported in 0.065% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic for autosomal recessive CFAP410-related disorders. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK). | Zampaglione E | Genetics in medicine : official journal of the American College of Medical Genetics | 2022 | PMID: 34906470 |
Homozygous variant in C21orf2 in a case of Jeune syndrome with severe thoracic involvement: Extending the phenotypic spectrum. | McInerney-Leo AM | American journal of medical genetics. Part A | 2017 | PMID: 28422394 |
Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands. | Zhang Q | Scientific reports | 2016 | PMID: 27596865 |
Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 Mutations. | Wang Z | PloS one | 2016 | PMID: 26974433 |
An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. | Wheway G | Nature cell biology | 2015 | PMID: 26167768 |
Text-mined citations for rs140451304 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.